DCE-MRI灌注参数与机器学习鉴别儿童及年轻成人中线胶质瘤
本研究回顾性纳入62例经组织学证实的中线胶质瘤患者(30例中线胶质母细胞瘤、32例弥漫性中线胶质瘤),均行3T MRI定量DCE-MRI灌注分析。通过比较灌注参数并采用四种分类器进行机器学习分类,发现95百分位数值鉴别效能最高。随机森林分类器联合rCBV、rCBF、Ve三参数组合获得最高交叉验证准确率76.67%±7.16%,敏感度80.00%。
要点
- DCE-MRI灌注参数95百分位数值对鉴别mGBM与DMG的效能优于均值、标准差及其他百分位数。
- 单参数中rCBF、rCBV、Ve鉴别mGBM与DMG的AUC范围为70.62%至75.31%。
- 随机森林联合rCBV+rCBF+Ve三参数组合的交叉验证准确率最高,达76.67%±7.16%,敏感度80.00%。
核心结论
- 定量DCE-MRI灌注分析对鉴别DMG与mGBM具有显著诊断价值,可在未获得组织诊断时提供无创替代方案。
- DMG的95百分位灌注参数值显著低于mGBM(p<0.05)。
- 单参数及优化后的多参数方法均展现出对指导治疗决策有临床实用价值的性能。
研究设计与样本
- 回顾性研究,纳入62例经组织学证实的中线胶质瘤患者,其中30例mGBM、32例DMG,均行3T MRI评估。
- 计算定量DCE-MRI灌注参数rCBV、rCBF、Slope-2、Ktrans、Vp、Ve,并对中线肿瘤类型间进行比较。
- 统计方法包括Shapiro-Wilk检验、t检验及基于灌注参数的ROC曲线分析。
- 机器学习分类采用四种分类器及5折交叉验证,评估灌注参数最佳特征中所有可能的特征组合。
关键影像表现/征象
- 在各参数图中提取的统计特征中,95百分位数值对mGBM与DMG的鉴别效能最高。
- DMG的95百分位灌注参数值显著低于mGBM(p<0.05)。
诊断标准与关键数值
- 单参数rCBF、rCBV、Ve鉴别mGBM与DMG的AUC范围为70.62%至75.31%。
- 随机森林分类器联合rCBV+rCBF+Ve三参数组合的交叉验证准确率为76.67%±7.16%,所有模型敏感度一致为80.00%。
- DMG由H3 K27改变分子定义,而mGBM缺乏该改变。
临床应用与阅片要点
- 当中线部位取材困难或未获得组织诊断时,可借助定量DCE-MRI灌注参数进行mGBM与DMG的无创鉴别。
- 阅片时优先关注DCE-MRI灌注参数图的95百分位数值,其鉴别效能优于均值、标准差及其他百分位测度。
- 灌注参数显著减低提示DMG可能,但鉴别仍需结合多参数综合分析以提高可靠性。
局限性
- 本研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Diffuse midline glioma (DMG) and midline glioblastoma (mGBM) are aggressive WHO grade 4 tumors with comparable median survival of 12-18 months but require fundamentally different therapeutic approaches. DMG is molecularly defined by H3 K27-alteration, whereas mGBM lacks this alteration, however, non-invasive differentiation remains challenging due to overlapping conventional MRI features and the difficulty of obtaining tissue diagnosis from eloquent midline locations.
METHODS: This retrospective study included 62 patients with histologically confirmed midline gliomas (30 mGBM, 32 DMG) evaluated with 3T MRI. Quantitative DCE-MRI perfusion parameters (rCBV, rCBF, Slope-2, Ktrans, Vp, Ve) were computed and compared between the midline tumor types. Statistical analyses included Shapiro-Wilk test, t-test, and ROC curve analysis using perfusion parameters. Machine learning-based classification was also performed using four classifiers and 5-fold cross-validation, evaluating all possible feature combinations among the best features from the perfusion parameters.
RESULTS: Among the statistical features extracted from each parametric map, the 95th percentile values showed the highest discriminative performance for differentiating mGBM from DMG, outperforming the mean, standard deviation, and other percentile measures. DMG exhibited significantly lower 95th percentile perfusion parameter values compared to mGBM (p < 0.05). Individual perfusion parameters, particularly rCBF, rCBV, Ve showed discriminative performance achieving AUC values ranging from 70.62% to 75.31%, for differentiating mGBM vs. DMG. Machine learning classifiers used these features for evaluating 7 combinations. Three parameter combination (rCBV + rCBF + Ve) using a random forest classifier achieved the highest cross-validation accuracy (76.67 ± 7.16%) with consistent sensitivity (80.00%) across all models.
CONCLUSIONS: Quantitative DCE-MRI perfusion analysis provides significant diagnostic value for differentiating DMG from mGBM, offering a non-invasive alternative when tissue diagnosis is not obtained. Both individual parameters and optimized multi-parametric approaches demonstrate clinically useful performance for guiding treatment decisions.
引用
- Kesari, Gupta, Ahlawat, et al. Non-invasive differentiation of diffuse midline glioma and midline glioblastoma using DCE-MRI perfusion parameters and machine learning classification in pediatric and young adult patients. Neuroradiology. 2026. PMID: 42671541. doi:10.1007/s00234-026-04156-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。